Augustine Therapeutics’ €17m Series A Funding Round

Deloitte Legal assisted Augustine Therapeutics with Series A round.Augustine Therapeutics, a pioneering biotech firm specializing in innovative treatments for neurodegenerative and cardiometabolic diseases, has announced that…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here